Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection

ClinicalTrials.gov ID: NCT00600925

Public ClinicalTrials.gov record NCT00600925. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Controlled, Phase 3 Study of Gentamicin-Collagen Sponge in General Surgical Subjects at Higher Risk for Surgical Wound Infection

Study identification

NCT ID
NCT00600925
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Innocoll
Industry
Enrollment
602 participants

Conditions and interventions

Interventions

  • gentamicin-collagen sponge dipped in saline Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2007
Primary completion
Feb 28, 2009
Completion
Aug 31, 2010
Last update posted
Sep 23, 2021

2008 – 2010

United States locations

U.S. sites
39
U.S. states
22
U.S. cities
39
Facility City State ZIP Site status
Not listed Florence Alabama
Not listed Mobile Alabama
Not listed Laguna Hills California
Not listed Los Angeles California
Not listed Stanford California
Not listed Aurora Colorado
Not listed Denver Colorado
Not listed Tampa Florida
Not listed Weston Florida
Not listed Atlanta Georgia
Not listed Indianapolis Indiana
Not listed Louisville Kentucky
Not listed New Orleans Louisiana
Not listed Baltimore Maryland
Not listed Detroit Michigan
Not listed Duluth Minnesota
Not listed Minneapolis Minnesota
Not listed St Louis Missouri
Not listed Albany New York
Not listed Brooklyn New York
Not listed New York New York
Not listed Syracuse New York
Not listed Chapel Hill North Carolina
Not listed Durham North Carolina
Not listed Greensboro North Carolina
Not listed Cincinnati Ohio
Not listed Cleveland Ohio
Not listed Columbus Ohio
Not listed Oklahoma City Oklahoma
Not listed Portland Oregon
Not listed Hershey Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Nashville Tennessee
Not listed Dallas Texas
Not listed Houston Texas
Not listed Temple Texas
Not listed Burlington Vermont
Not listed Seattle Washington
Not listed Tacoma Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00600925, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00600925 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →